Drug Database
Back to search

Belgium· BE-AMP-SAM475422-00

Kengrexal 50 mg

A cangrelor product containing cangrelor tetrasodium, registered in Belgium by Chiesi Farmaceutici. The same ATC class is registered in 13 of our 19 countries.

ATC B01AC25

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedKengrexal 50 mgATCB01AC25REGISTER NO.BE-AMP-SAM475422-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about cangrelor tetrasodiumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Cangrelor is registered in 13 of 19 countries.

Countries holding a registration under ATC B01AC25 (cangrelor), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose
Search cangrelor products by name

Cangrelor · ATC B01AC25

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Cangrelor Tetrasodium
Manufacturer
Chiesi Farmaceutici
Country
Belgium (BE)
ATC code
B01AC25
ATC class
Cangrelor
Defined daily dose
50 mg, P
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7729213
  • be_apb
    3788320

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

135 interactions on record for cangrelor.

Graded by severity as the source publishes them — 65 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check cangrelor against other medicinesHow interaction checks work

Cangrelor · interactions on record

135 records

  • 65 severe
  • 70 moderate

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • HeparinB01AB01severe
  • Antithrombin IIIB01AB02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cangrelor in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cangrelor products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Kengrexal
  • Liechtenstein · Kengrexal
  • Norway · Kengrexal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e9b59649-cf78-4450-add9-5583f5052c34
GET /v1/drugs/e9b59649-cf78-4450-add9-5583f5052c34?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for concentrate for solution for injection/infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Kengrexal 50 mg",
  "name_fr": "Kengrexal 50 mg",
  "name_nl": "Kengrexal 50 mg",
  "amp_code": "SAM475422-00",
  "strengths": [
    "50.0000",
    "52.2000"
  ],
  "pack_count": 1,
  "substances": [
    "Cangrelor Tetrasodium",
    "Cangrelor",
    "Mannitol",
    "Sodium Hydroxide",
    "Sorbitol"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Cangrelor",
  "authorisation_numbers": [
    "EU/1/15/994/001"
  ]
}
API referenceMCP serverPlans

See everything about cangrelor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console